牛叉诊股

同花顺高级诊股公告

同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！

同花顺特色产品: 〈高级诊股〉 全方位深度分析，提供明确投资建议

恩威医药（301331）

5.7

综合诊断：5.7分打败了80%的股票！

卖出
减持
中性
增持
买入

短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
中期趋势：
下跌有所减缓，仍应保持谨慎。
长期趋势：
已有57家主力机构披露2026-06-30报告期持股数据，持仓量总计7216.51万股，占流通A股70.34%
波段诊断：
-
历史波段诊断>>

高级诊股策略资深顾问建议

分享到：

加自选 向专家提问

技术面诊股资金面诊股消息面诊股行业面诊股基本面诊股

6.4分

6.2分

5.5分

3.2分

5.5分

风险提示：诊断结果通过运算模型加工客观数据而成，仅供参考，不构成绝对投资建议。

技术面诊股

诊断结果：6.4技术面打败了80%的股票技术面评分前10的股票

近期的平均成本为21.66元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。

技术面得分最高的股票

平均成本

近期的平均成本为21.66元。

[{"text":"\u5e73\u5747\u6210\u672c","value":"21.66","date":1790152089,"color":"0x9f0ba1"}]

市场表现

过去10个交易日，该股走势跑赢大盘，明显跑赢行业平均水平。

[{"date":"2026.09.24","stock":"-1.10","trade":"-1.25","ind":"-2.34"},{"date":"2026.09.23","stock":"-0.36","trade":"-1.22","ind":"-0.64"},{"date":"2026.09.22","stock":"2.24","trade":"-0.02","ind":"-0.05"},{"date":"2026.09.21","stock":"4.03","trade":"3.26","ind":"0.65"},{"date":"2026.09.18","stock":"0.44","trade":"0.53","ind":"1.72"},{"date":"2026.09.17","stock":"0.93","trade":"0.47","ind":"-0.33"},{"date":"2026.09.16","stock":"0.49","trade":"0.02","ind":"1.26"},{"date":"2026.09.15","stock":"-3.66","trade":"-1.87","ind":"-0.72"},{"date":"2026.09.14","stock":"1.35","trade":"1.60","ind":"-0.64"},{"date":"2026.09.11","stock":"-2.36","trade":"-2.01","ind":"-1.08"},{"date":"2026.09.10","stock":"-3.63","trade":"-2.32","ind":"-0.77"},{"date":"2026.09.09","stock":"-0.72","trade":"-0.82","ind":"0.15"},{"date":"2026.09.08","stock":"2.07","trade":"1.65","ind":"-0.52"},{"date":"2026.09.07","stock":"1.40","trade":"0.39","ind":"1.91"},{"date":"2026.09.04","stock":"-0.60","trade":"-0.06","ind":"-0.79"},{"date":"2026.09.03","stock":"-1.15","trade":"-0.59","ind":"0.10"},{"date":"2026.09.02","stock":"-1.13","trade":"-1.51","ind":"-1.88"},{"date":"2026.09.01","stock":"0.36","trade":"1.64","ind":"-1.02"},{"date":"2026.08.31","stock":"0.69","trade":"-1.74","ind":"0.44"},{"date":"2026.08.28","stock":"-0.86","trade":"0.09","ind":"-0.68"},{"date":"2026.08.27","stock":"-0.09","trade":"1.05","ind":"1.50"}]

恩威医药,深证成指,中药指数

压力支撑

该股压力位为21.82元，支撑位为21.19元。

[{"text":"\u538b\u529b\u4f4d","value":"21.82","date":1790179200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"21.19","date":1790179200,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前反弹趋势有所减缓，投资者可适当关注。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：6.2资金面打败了82%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力集中了一定的筹码，呈中度控盘状态。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

中药行业，近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。

更新时间：09月24日 20:31

机构今日流向(万元)	-2053.20	机构5日流向(万元)	-2317.90
机构10日流向(万元)	-5191.92	机构20日流向(万元)	-15042.87

机构持仓

2026-06-30 与 2025-12-31 相比，主力机构持仓量减少29.07万股，其中基金净减仓4家，主力净增仓26家，暂未发现中长期投资价值。

截止2026-06-30，共57家主力机构（基金49家，一般法人6家，QFII1家，券商1家），持仓量总计7216.51万股，占流通A股70.34%
其中，基金持仓与2025-12-31相比：
增仓：0家，增持 0万股
减仓：4家，减持 0.73万股
新出现在主力名单中：47家，持有454.13万股
从主力名单中消失：21家，原持有82.47万股

消息面诊股

诊断结果：5.5消息面打败了45%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	募资投向		2026-09-16
一般消息	分红转增	不分配不转增	2026-08-27
一般消息	重大事项	公司股东股份解押	2026-08-27
一般消息	重大事项	公司股东股份解押	2026-08-25
一般消息	募资投向	公司出售资产	2026-07-30
一般消息	募资投向	公司购买资产	2026-07-30
一般消息	重大事项	公司股东股份解押	2026-07-13
一般消息	重大事项	公司股东股份冻结	2026-06-11
一般消息	重大事项	公司股东股份解押	2026-05-25
一般消息	股东大会	年度股东大会	2026-04-27
利好	分红转增	10派6.8元(含税)	2026-04-27
一般消息	重大事项	公司股东股份解押	2026-04-16
一般消息	资产重组	公司股权转让	2026-02-02
重大利好	业绩预告	业绩大幅上升	2026-01-20
利好	分红转增	10派3.5元(含税)	2025-12-26
一般消息	重大事项	公司股东股份解押	2025-11-26
一般消息	重大事项	公司股东股份解押	2025-11-20

一年消息统计

	所有消息	重大消息	非重大消息
利好	3条	1条	2条
利空	0条	0条	0条

行业面诊股

诊断结果：3.2行业面打败了25%的股票中药行业最新资金流向

近10日来该行业走势不明显，跑赢大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，跑赢大盘。

[{"date":"2026.09.24","price":"-2.34","value":"-1.25"},{"date":"2026.09.23","price":"-0.64","value":"-1.22"},{"date":"2026.09.22","price":"-0.05","value":"-0.02"},{"date":"2026.09.21","price":"0.65","value":"3.26"},{"date":"2026.09.18","price":"1.72","value":"0.53"},{"date":"2026.09.17","price":"-0.33","value":"0.47"},{"date":"2026.09.16","price":"1.26","value":"0.02"},{"date":"2026.09.15","price":"-0.72","value":"-1.87"},{"date":"2026.09.14","price":"-0.64","value":"1.60"},{"date":"2026.09.11","price":"-1.08","value":"-2.01"},{"date":"2026.09.10","price":"-0.77","value":"-2.32"},{"date":"2026.09.09","price":"0.15","value":"-0.82"},{"date":"2026.09.08","price":"-0.52","value":"1.65"},{"date":"2026.09.07","price":"1.91","value":"0.39"},{"date":"2026.09.04","price":"-0.79","value":"-0.06"},{"date":"2026.09.03","price":"0.10","value":"-0.59"},{"date":"2026.09.02","price":"-1.88","value":"-1.51"},{"date":"2026.09.01","price":"-1.02","value":"1.64"},{"date":"2026.08.31","price":"0.44","value":"-1.74"},{"date":"2026.08.28","price":"-0.68","value":"0.09"},{"date":"2026.08.27","price":"1.50","value":"1.05"}]

深证成指,中药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	ST万邦	22.82%	25.39%	6.4分
2	精华制药	17.99%	5.35%	5.2分
3	天目药业	14.01%	3.97%	6.3分
4	华神科技	10.90%	19.39%	5.8分
5	沃华医药	9.13%	7.17%	6.8分
6	三力制药	8.10%	2.20%	5.6分
7	特一药业	6.19%	3.56%	5.8分
8	ST嘉应	4.03%	-2.43%	4.8分
9	康惠股份	2.46%	-7.18%	4.2分
10	千金药业	2.31%	8.01%	5.3分
11	云南白药	1.88%	-0.95%	6.3分
12	方盛制药	1.68%	0.59%	5.2分
13	ST百灵	0.22%	3.36%	5.5分
14	益盛药业	-0.57%	-0.85%	4.8分
15	振东制药	-1.33%	0.00%	4.6分
16	寿仙谷	-1.36%	3.64%	5.1分
17	粤万年青	-1.63%	2.66%	5.9分
18	太龙药业	-1.71%	3.75%	5.9分
19	恩威医药	-1.91%	5.26%	5.7分
20	广誉远	-1.94%	0.81%	5.4分
21	康缘药业	-2.01%	0.91%	5.6分
22	新光药业	-2.48%	4.67%	5.4分
23	桂林三金	-2.73%	-0.08%	6.0分
24	济川药业	-3.21%	-2.94%	5.3分
25	新天药业	-3.23%	3.46%	5.7分
26	ST金花	-3.27%	0.00%	5.0分
27	健民集团	-3.32%	2.21%	5.8分
28	ST葫芦娃	-3.36%	0.88%	4.2分
29	奇正藏药	-3.44%	1.79%	5.3分
30	达仁堂	-3.49%	3.20%	5.8分
31	白云山	-3.82%	-0.05%	4.9分
32	古汉医药	-3.96%	0.34%	4.5分
33	同仁堂	-4.15%	0.52%	5.1分
34	-	-4.30%	2.30%	分
35	亚宝药业	-4.71%	1.06%	5.6分
36	康美药业	-5.00%	-0.75%	4.0分
37	华润三九	-5.07%	-1.89%	5.4分
38	东阿阿胶	-5.25%	-0.92%	5.3分
39	-	-5.27%	0.00%	分
40	羚锐制药	-5.33%	-1.52%	5.4分
41	马应龙	-5.86%	-1.25%	5.2分
42	华润江中	-5.87%	-0.98%	5.3分
43	信邦制药	-6.13%	-1.02%	5.2分
44	步长制药	-6.38%	-0.68%	5.5分
45	吉林敖东	-6.42%	0.98%	5.4分
46	佛慈制药	-6.44%	-1.69%	5.2分
47	佐力药业	-6.57%	0.78%	5.5分
48	康恩贝	-6.65%	-0.47%	5.0分
49	九芝堂	-6.78%	-0.93%	5.4分
50	以岭药业	-6.83%	0.13%	5.2分
51	昆药集团	-6.94%	-0.86%	4.8分
52	片仔癀	-7.10%	-0.37%	5.6分
53	仁和药业	-7.40%	-0.97%	4.7分
54	盘龙药业	-7.59%	2.39%	5.3分
55	天士力	-7.69%	-1.87%	5.1分
56	太极集团	-7.88%	-0.22%	4.9分
57	红日药业	-8.62%	-0.31%	4.7分
58	维康药业	-9.49%	-2.46%	5.3分
59	中恒集团	-10.50%	-3.62%	4.0分
60	众生药业	-10.54%	-5.24%	5.4分
61	华森制药	-11.42%	6.26%	6.5分
62	益佰制药	-11.52%	1.98%	4.6分
63	珍宝岛	-11.77%	-2.64%	4.5分
64	上海凯宝	-12.73%	3.37%	5.4分
65	葵花药业	-15.17%	0.18%	4.7分
66	*ST香雪	-15.87%	-13.00%	4.3分
67	陇神戎发	-20.00%	8.81%	5.4分
68	汉森制药	-35.09%	2.71%	5.7分

<上一页 1 2 3 4 5...12 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：5.5基本面打败了38%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，暂时未获得多数机构的显著认同，后续可继续关注。

个股深一度

潜在高分红能力：中（90分）

基本面得分最高的股票

[ 截止日期：2026-06-30 ]公司经营

盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 46/109 ， 40/109。

[{"date":"2026-06-30","value":"1.53","vol":"3.25"},{"date":"2026-03-31","value":"1.16","vol":"2.21"},{"date":"2025-12-31","value":"4.88","vol":"-2.33"},{"date":"2025-09-30","value":"3.42","vol":"4.80"},{"date":"2025-06-30","value":"3.58","vol":"4.03"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
净资产收益率(%)	1.53	1.16	4.88	3.42	3.58
行业(%)	3.25	2.21	-2.33	4.80	4.03

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-06-30","value":"51.18","vol":"53.70"},{"date":"2026-03-31","value":"55.69","vol":"55.05"},{"date":"2025-12-31","value":"49.51","vol":"52.85"},{"date":"2025-09-30","value":"48.22","vol":"53.29"},{"date":"2025-06-30","value":"49.10","vol":"53.82"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
销售毛利率(%)	51.18	55.69	49.51	48.22	49.10
行业(%)	53.70	55.05	52.85	53.29	53.82

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 48/109 ， 57/109。

[{"date":"2026-06-30","value":"-16.62","vol":"-9.08"},{"date":"2026-03-31","value":"-10.77","vol":"-5.58"},{"date":"2025-12-31","value":"10.91","vol":"-6.76"},{"date":"2025-09-30","value":"13.65","vol":"-7.84"},{"date":"2025-06-30","value":"15.73","vol":"-7.78"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
营业收入同比增长率(%)	-16.62	-10.77	10.91	13.65	15.73
行业(%)	-9.08	-5.58	-6.76	-7.84	-7.78

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-06-30","value":"-58.21","vol":"-101.51"},{"date":"2026-03-31","value":"-23.31","vol":"1.06"},{"date":"2025-12-31","value":"38.53","vol":"-80.25"},{"date":"2025-09-30","value":"66.13","vol":"-2.78"},{"date":"2025-06-30","value":"113.80","vol":"2.25"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
净利润同比增长率(%)	-58.21	-23.31	38.53	66.13	113.80
行业(%)	-101.51	1.06	-80.25	-2.78	2.25

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 25/109 ， 14/109。

[{"date":"2026-06-30","value":"0.25","vol":"0.22"},{"date":"2026-03-31","value":"0.12","vol":"0.12"},{"date":"2025-12-31","value":"0.59","vol":"0.47"},{"date":"2025-09-30","value":"0.42","vol":"0.35"},{"date":"2025-06-30","value":"0.30","vol":"0.24"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
总资产周转率(次)	0.25	0.12	0.59	0.42	0.30
行业(次)	0.22	0.12	0.47	0.35	0.24

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-06-30","value":"1.58","vol":"1.14"},{"date":"2026-03-31","value":"0.68","vol":"0.59"},{"date":"2025-12-31","value":"4.20","vol":"2.34"},{"date":"2025-09-30","value":"2.87","vol":"1.72"},{"date":"2025-06-30","value":"2.00","vol":"1.17"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
存货增长率(次)	1.58	0.68	4.20	2.87	2.00
行业(次)	1.14	0.59	2.34	1.72	1.17

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 19/109 ， 49/109。

[{"date":"2026-06-30","value":"34.91","vol":"20.65"},{"date":"2026-03-31","value":"-1.99","vol":"5.83"},{"date":"2025-12-31","value":"12.65","vol":"30.77"},{"date":"2025-09-30","value":"0.54","vol":"10.53"},{"date":"2025-06-30","value":"19.98","vol":"22.82"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
现金流量净额/营业收入	34.91	-1.99	12.65	0.54	19.98
行业	20.65	5.83	30.77	10.53	22.82

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-06-30","value":"1.02","vol":"0.88"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"1.08","vol":"1.00"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.34","vol":"1.03"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
资本支出／折旧和摊销	1.02	-	1.08	-	1.34
行业	0.88	0.00	1.00	0.00	1.03

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 52/109 ， 54/109。

[{"date":"2026-06-30","value":"4.21","vol":"3.10"},{"date":"2026-03-31","value":"2.36","vol":"2.97"},{"date":"2025-12-31","value":"2.14","vol":"2.94"},{"date":"2025-09-30","value":"4.44","vol":"3.09"},{"date":"2025-06-30","value":"4.11","vol":"2.94"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
流动比率	4.21	2.36	2.14	4.44	4.11
行业	3.10	2.97	2.94	3.09	2.94

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-06-30","value":"3.43","vol":"2.34"},{"date":"2026-03-31","value":"1.95","vol":"2.23"},{"date":"2025-12-31","value":"1.86","vol":"2.15"},{"date":"2025-09-30","value":"3.76","vol":"2.24"},{"date":"2025-06-30","value":"3.53","vol":"2.15"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
速动比率	3.43	1.95	1.86	3.76	3.53
行业	2.34	2.23	2.15	2.24	2.15

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 28/109 ， 31/109。

[{"date":"2026-06-30","value":"28.92","vol":"32.07"},{"date":"2026-03-31","value":"27.53","vol":"31.94"},{"date":"2025-12-31","value":"30.82","vol":"32.43"},{"date":"2025-09-30","value":"27.60","vol":"31.59"},{"date":"2025-06-30","value":"28.57","vol":"32.45"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
资产负债率(%)	28.92	27.53	30.82	27.60	28.57
行业(%)	32.07	31.94	32.43	31.59	32.45

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-06-30","value":"0.41","vol":"0.68"},{"date":"2026-03-31","value":"0.38","vol":"0.66"},{"date":"2025-12-31","value":"0.45","vol":"0.67"},{"date":"2025-09-30","value":"0.38","vol":"0.76"},{"date":"2025-06-30","value":"0.40","vol":"0.75"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
产权比率 (%)	0.41	0.38	0.45	0.38	0.40
行业(%)	0.68	0.66	0.67	0.76	0.75

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

暂时还没有机构预测该股2026年的收益，请投资者后续关注。

[{"date":"2022","yellowRectValue":"0.68","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.86","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.37","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.52","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]

[恩威医药]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]